Archive | POGO RSS for this section

POGO Announcement- Dr. Corin Greenberg to step down as POGO CEO

ON BEHALF OF HON. STEPHEN GOUDGE

As President of the Board of Directors of the Pediatric Oncology Group of Ontario (POGO), I have important news to share with our partners and colleagues.

Dr. Corin Greenberg has informed the Board and POGO staff of her decision to step down as Chief Executive Officer (CEO) once a successor is recruited. Corin remains unqualifiedly committed to our enduring POGO mission, to seeing the organization well settled with new leadership, and to her ongoing work with so many of you.

Under Corin’s leadership, POGO has enjoyed great success in moving its mission, vision and strategic plan for improving the childhood cancer agenda forward and for improving the lives of children with cancer, the lives of their families and of the professionals who care for them. POGO is recognized for its advisory role to Ministry of Health and Long-term Care (MOHLTC) and as the consensus voice for pediatric oncology in Ontario. The organization fulfills a trend-setting role as an enduring multi-disciplinary, multi-centred collaboration that has delivered clinical initiatives, health care policy, education and research advances in childhood cancer control.

Corin led the original collaboration of the pediatric oncology community to determine the needs and gaps in the system and to create the first provincial plan for childhood cancer in Ontario (1987/88), and then subsequently co-led several provincial pediatric oncology plan collaborations. She promoted equity of access to care through ratio-based staffing for a multi-disciplinary pediatric oncology team and established the POGO Chair in Childhood Cancer Control. Her work set the stage for POGO’s unique planning and collaborative activity and she established the provincial headquarters of POGO, its mandate, foundational activities and a firm financial footing.

Corin’s contributions and leadership have been, and continue to be, simply stated, truly outstanding.

I will be chairing the search committee that will lead the recruitment of new CEO of POGO. We are committed to finding an outstanding leader who will build on the significant accomplishments of POGO to date. We are indeed fortunate to have Corin continue in her role as CEO until a successor is in place, for which I am very grateful.

We look forward to properly celebrating Corin’s many achievements at a future date.

Advertisements

Synoptic Reporting Webinar: Pediatric Patients with Ewing Sarcoma (22-Mar-2017, 1pm EST, free registration requi

Presented by:

Dr. Dina El Demellawy, MD, PhD, FRCPC
Pediatric Pathologist, Children’s Hospital of Eastern Ontario (CHEO)
Associate Professor, University of Ottawa and the University of Northern Ontario School of Medicine

Wednesday, March 22, 2017
1:00 – 2:30 p.m. EST (60 minutes presentation; 30 minutes Q & A)

Learning Objectives:

  1. To review the College of American Pathologists’ (CAP) protocols related to Ewing Sarcoma and its use by pathologists specializing in pediatric oncology.
  2. To understand changes in the latest revision of the CAP cancer protocols and electronic cancer checklists.

This webinar will provide expert advice for advancing pediatric oncology through optimal pathology investigation, moving toward standardized reporting, and incremental clarity of clinical implications.

Background:

As part of POGO’s long-range plan for childhood cancer in Ontario, a task force was initiated in 2012 to determine reporting protocols currently in use, to review/ generate/ approve reporting templates and conventions, and to recommend future practice in Ontario. The task force identified and endorsed the College of American Pathologists’ (CAP) Ewing Sarcoma protocol as the expert consensus-based approach to reporting and is recommending its adoption in Ontario. The task force is co-chaired by Dr. Joseph de Nanassy (Division Chief, Anatomical Pathology, Children’s Hospital of Eastern Ontario), Dr. Gino Somers (Head, Division of Pathology, Hospital for Sick Children) and Dr. David Malkin (POGO’s Medical Director from 2011-2016).

Participation details:

Please visit http://www.pogo.ca/education/synoptic-reporting/ to register for this free webinar. Webinar login details will be provided upon confirmation. Your registration by March 17 is suggested.

Questions? Contact Jamie Irvine, Assistant to the Conference & Educational Events Coordinator at jirvine@pogo.ca or 416-592-1232, ext. 227.

Synoptic Reporting Webinar: Pediatric Patients with Rhabdomyosarcoma, presented by Dr. Gino Somers (May 11, 1:30 EDT). See post for registration details

Wednesday, May 11, 2016   1:00 – 2:30 p.m. EST  (60 minutes presentation; 30 minutes Q & A)

Presented by: Dr. Gino Somers, MBBS, BMedSc, PhD, FRCPA
Co-Chair, POGO’s Pathology & Molecular Diagnostics Task Force
Head, Division of Pathology, Hospital for Sick Children, Toronto

This webinar will provide expert advice for advancing pediatric oncology toward standardized reporting of pathology specimens; optimal pathology investigation; incremental clarity of clinical implications; and unprecedented analytics.

Learning Objectives:

  1. To review the College of American Pathologists’ (CAP) protocols related to Rhabdomyosarcoma and its use by pathologists specializing in pediatric oncology.
  2. To understand changes in the latest revision of the CAP cancer protocols and electronic cancer checklists.

Background:  As part of POGO’s long-range plan for childhood cancer in Ontario, a task force was initiated, co-chaired by Dr. Joseph de Nanassy (Division Chief, Anatomical Pathology, Children’s Hospital of Eastern Ontario), Dr. Gino Somers (Head, Division of Pathology, Hospital for Sick Children) and Dr. David Malkin, POGO’s Medical Director, to determine reporting protocols currently in use, to review/generate/approve reporting templates and conventions, and to recommend future practice in Ontario. The task force identified and endorsed the College of American Pathologists’ (CAP) existing Rhabdomyosarcoma protocol as the expert consensus-based approach to reporting and is recommending its adoption in Ontario.

Participation details:  Please visit http://www.pogo.ca/education/synoptic-reporting/ to register for this webinar. Webinar login details will be provided upon confirmation. Your registration by May 9 is suggested. Questions? Contact Clara Jordan, Conference & Educational Events Coordinator at cjordan@pogo.ca or 416-592-1232, ext. 237.

POSTING: Medical Director Pediatric Oncology Group of Ontario (POGO) AND POGO Chair in Childhood Cancer Control

The Pediatric Oncology Group of Ontario (POGO) is seeking a Medical Director which is associated with an endowed Chair in Childhood Cancer Control at the University of Toronto, tenable at any of the Faculties of Medicine/Health Sciences in Ontario; this unique combination sustains an interface between the academic sector, policy makers and healthcare providers united in the common goal of improving the circumstances of the children and adolescents in Ontario who are diagnosed with cancer, and their families. POGO is an inter-institutional, policy, planning and research entity that works closely with all pediatric oncology providers to coordinate childhood cancer control for the province of Ontario and advises Ontario’s Ministry of Health and Long-Term Care regarding healthcare policy for children with malignant disease. The term is five years, renewable for a further five-year term following a successful review in accordance with POGO and University policies. Effective date of appointment is August 1, 2016.

Salary for the position will be commensurate with qualifications and experience; and in the range of $200,000-$400,000 annually; plus, as applicable, any clinical fee for service as a result of the candidate’s activities.
Interested candidates should apply by October 31, 2015.

For more information and to read the entire posting see POGO Medical Director and Chair Posting.

POGO WEBINAR: Synoptic Pathology Reporting for Pediatric Patients with Neuroblastoma

Dr. Joseph de Nanassy, MD FRCPC CCPE MCHM, Site Chief, Department of Laboratory Medicine & Division Chief, Anatomical Pathology, Children’s Hospital of Eastern Ontario, Ottawa, ON; Associate Professor, University of Ottawa; Member, POGO Pathology and Molecular Diagnostic Task Force

Date:               Thursday, June 18, 2015

Time:              1:00 – 2:30 p.m. (60 minutes presentation; 30 minutes Q & A)

Audience:        Pathologists, Pathology Fellows and Residents; Pediatric Oncologists, Surgeons, Radiation Oncologists; Clinical Research Associates (CRA’s).  This webinar will provide expert advice for advancing pediatric oncology toward standardized reporting of pathology specimens; optimal pathology investigation; incremental clarity of clinical implications; and unprecedented analytics.  Presented in partnership with the Canadian Partnership Against Cancer (CPAC)

As part of POGO’s long-range plan for childhood cancer in Ontario, a task force was initiated, co-chaired by Dr. Gino Somers, Head, Division of Pathology, Hospital for Sick Children, and Dr. David Malkin, POGO’s Medical Director, to determine reporting protocols currently in use, to review/ generate/ approve reporting templates and conventions, and to recommend future practice in Ontario. The task force identified and endorsed the pediatric College of American Pathologists’ (CAP) protocols and is recommending their adoption in Ontario.

Learning Objectives:

  1. To review the CAP protocols related to Neuroblastoma and its use by pathologists specializing in pediatric oncology.
  2. To understand changes in the latest revision of the CAP cancer protocols and electronic cancer checklists.

Participation details: Please confirm your participation in this webinar at http://www.pogo.ca/education/synoptic-reporting/ to register online. For questions about registration, please contact Emily Bain at ebain@pogo.ca or 416-592-1232 ext. 227. Webinar login details will be provided in advance of the event. Your confirmation by June 16 (at 5 p.m.) is suggested.